PE-35-related antigen expression and CD1a-positive lymphocytes in thymoma subtypes based on Muller-Hermelink classification. An immunohistochemical study using catalyzed signal amplification

Virchows Archiv

Volumn 436, Issue 1, 2000, Pages 20-27

  Hattori, Hideo ^a   Tateyama, Hisashi ^a   Tada, Toyohiro ^a   Saito, Yushi ^a   Yamakawa, Yosuke ^a   Eimoto, Tadaaki ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Catalyzed signal amplification (CSA); CD1a; Immunohistochemistry; PE 35; Thymic carcinoma; Thymoma

Indexed keywords

CD1 ANTIGEN; MONOCLONAL ANTIBODY;

ANTIGEN EXPRESSION; ARTICLE; CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE; PRIORITY JOURNAL; THYMOMA; TUMOR CLASSIFICATION;

EID: 0033994110     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00008194     Document Type: Article

References (32)

1. 1. Bobrow MN, Harris TD, Shughnessy KJ, Litt GJ (1989) Catalyzed reporter deposition, a novel method of signal amplification: application to immunoassays. J Immunol Methods 125: 279-285
2. 2. Chan WC, Zaatari GS, Tabei S, Bibb M, Brynes RK (1984) Thymoma: an immunohistochemical study. Am J Clin Pathol 82: 160-166
3. 3. De Maagd RA, MacKenzie WA, Schuurman H-J, Ritter MA, Price KM, Broekhuizen R, Kater L (1985) The human thymus microenvironment: heterogeneity detected by monoclonal anti-epithelial antibodies. Immunology 54:745-754
4. 4. Eimoto T, Teshima K, Shirakusa T, Takeshita M, Okamura H, Naito H, Mitsui T, Kikuchi M (1986) Heterogeneity of epithelial cells and reactive components in thymomas: an ultrastructural and immunohistochemical study. Ultrastruct Pathol 10: 157-173
5. 5. Fukai I, Masaoka A, Hashimoto T, Yamakawa Y, Mizuno T, Tanamura O, Hirokawa K, Ueda R (1992) An immunohistochemical study of the epithelial components of 81 cases of thymoma. Cancer 69:2463-2468
6. 6. Garcia RL, Coltrela MD, Gown AM (1989) Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissue: comparison with flow cytometric analysis. Am J Pathol 134:733-739
7. 7. Ho FCS, Fu KH, Lam SY, Chiu SW, Chan ACL, Müller-Hermelink HK (1994) Evaluation of a histologic classification for thymic epithelial tumours. Histopathology 25:21-29
8. 8. Kirchner T, Müller-Hermelink HK (1989) New approaches to the diagnosis of thymic epithelial tumors. Prog Surg Pathol 10: 167-189
9. 9. Kirchner T, Schalke B, Buchwaid J, Ritter M, Mark A, Müller-Hermelink HK (1992) Well-differentiated thymic carcinoma: an organotypical low-grade carcinoma with relationship to cortical thymoma. Am J Surg Pathol 16:1153-1169
10. 10. Kodama T, Watanabe S, Sato Y, Shimosato Y, Miyazawa N (1986) An immunohistochemical study of thymic epithelial tumors. I. Epithelial components. Am J Surg Pathol 10:26-33
11. 11. Kornstein MJ (1992) Controversies regarding the pathology of thymomas. Pathol Ann 27:1-15
12. 12. Kornstein MJ, Curran WJ, Jr, Turrisi AT III, Brooks JJ (1988) Cortical versus medullary thymomas: a useful morphologic distinction? Hum Pathol 19:1335-1339
13. 13. Krenacs L, Tiszlavicz L, Krenacs T, Boumsell L (1993) Immunohistochemical detection of CD1a antigen in formalin-fixed and paraffin-embedded tissue sections with monoclonal antibody O10. J Pathol 171:99-104
14. 14. Kuo T-T, Lo S-K (1993) Thymoma: a study of the pathologic classification of 71 cases with evaluation of Müller-Hermelink system. Hum Pathol 24:766-771
15. 15. Kuo T-T, Lo S-K (1997) Immunohistochemical metallothionein expression in thymoma: correlation with histological types and cellular origin. Histopathology 30:243-248
16. 16. Lattes R (1962) Thymoma and other tumors of the thymus. An analysis of 107 cases. Cancer 15:1224-1260
17. 17. Lewis JE, Wick MR, Scheithauer BW, Bernatz PE, Taylor WF (1987) Thymoma: a clinicopathologic review. Cancer 60: 2727-2743
18. 18. Lobach DF, Scearce RM, Haynes BF (1985) The human thymic microenvironment. Phenotypic characterization of Hassall's bodies with the use of monoclonal antibodies. J Immunol 134:250-257
19. 19. Maggi G, Giaccone G, Donadio M, Ciuffreda L, Dalesio O, Leria G, Trifiletti G, Casadio C, Palestro G, Mancuso M, Calciati A (1986) Thymomas: a review of 169 cases, with particular reference to results of surgical treatment. Cancer 58:765-776
20. 20. Marino M, Müller-Hermelink HK (1985) Thymoma and thymic carcinoma: relation of thymoma epithelial cells to the cortical and medullary differentiation of thymus. Virchows Arch 407:119-149
21. 21. Masaoka A, Monden Y, Nakahara K, Tanioka T (1981) Follow-up study of thymomas with special reference to their clinical stages. Cancer 48:2485-2492
22. 22. Mokhtar N, Hsu S-M, Lad RP, Haynes BF, Jaffe ES (1984) Thymoma: lymphoid and epithelial components mirror the phenotype of normal thymus. Hum Pathol 15:378-384
23. 23. Pescarmona E, Rendina EA, Venuta F, Ricci C, Ruco LP, Baroni CD (1990) The prognostic implication of thymoma histologic subtyping: a study of 80 consecutive cases. Am J Clin Pathol 93:190-195
24. 24. Prasad ML, Hyjek E, Giri DD, Ying L, O'Leary JJ, Hoda SA (1999) Double immunolabeling with cytokeratin and smooth-muscle actin in confirming early invasive carcinoma of breast. Am J Surg Pathol 23:176-181
25. 25. Quintanilla-Martinez L, Wilkins EW, Jr, Ferry JA, Harris NL (1993) Thymoma-morphologic subclassification correlates with invasiveness and immunohistologic features: a study of 122 cases. Hum Pathol 24:958-969
26. 26. Quintanilla-Martinez L, Wilkins EW, Jr, Choi N, Efird J, Hug E, Harris NL (1994) Thymoma: histologic subclassification is an independent prognostic factor. Cancer 74:606-617
27. 27. Sato Y, Watanabe S, Mukai K, Kodama T, Upton MP, Goto M, Shimosato Y (1986) An immunohistochemical study of thymic epithelial tumors. II. Lymphoid component. Am J Surg Pathol 10:862-870
28. 28. Shimosato Y, Mukai K (1997) Tumors of the mediastinum. In: Rosai J (ed) Atlas of tumor pathology, 3rd series. Fascicle 21. Armed Forces Institute of Pathology, Washington DC, pp 40-158
29. 29. Suster S, Moran CA (1996) Primary thymic epithelial neoplasms showing combined features of thymoma and thymic carcinoma: a clinicopathologic study of 22 cases. Am J Surg Pathol 20:1469-1480
30. 30. Takahashi T, Ueda R, Song X, Nishida K, Shinzato M, Namikawa R, Ariyoshi Y, Ota K, Kato K, Nagatsu T, Imaizumi M, Abe T, Takahashi T (1986) Two novel cell surface antigens on small cell lung carcinoma defined by mouse monoclonal antibodies NE-25 and PE-35. Cancer Res 46: 4770-4775
31. 31. Takahashi T, Ueda R, Nishida K, Namikawa R, Fukami H, Matsuyama M, Masaoka A, Imaizumi M, Takahashi T (1988) Immunohistochemical analysis of thymic tumors with PE-35 monoclonal antibody reactive with medullary thymic epithelium. Cancer Res 48:1896-1903
32. 32. Willcox N, Schluep M, Ritter MA, Schuurman HJ, Newsom-Davis J, Christensson B (1987) Myasthenic and nonmyasthenic thymoma: an expansion of a minor cortical epithelial cell subset? Am J Pathol 127:447-460